Description

LEESGGGLVQPGGSMK, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α[1].—COVID-19-immunoregulation–C64H108N18O24S—-[1]Dorothée LEBERT, et al. A method for quantifying therapeutic antibodies. EP3371592A1.–2096980-79-7–1545.71—-CC(C)C[C@H](N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(NCC(NCC(NCC(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N1[C@@H](CCC1)C(NCC(NCC(N[C@@H](CO)C(N[C@@H](CCSC)C(N[C@H](C(O)=O)CCCCN)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O–Inflammation/Immunology–10 mM in H2O–TNF Receptor—-Apoptosis–Peptides